- Home
- EVMN vs HQL Comparison
EVMN vs HQL Comparison
Compare EVMN & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | HQL |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 510.2M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVMN | HQL |
|---|---|---|
| Price | $21.90 | $17.10 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | 92.4K | ★ 120.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $3,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | ★ 40.00 | N/A |
| 52 Week Low | $16.70 | $11.34 |
| 52 Week High | $24.03 | $14.37 |
Technical Indicators
Market Signals| Indicator | EVMN | HQL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.19 |
| Support Level | N/A | $16.86 |
| Resistance Level | N/A | $17.70 |
| Average True Range (ATR) | 0.00 | 0.37 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 56.30 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.